Timothée Boyer‐Chammard

AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial

David S. Lawrence, Nabila Youssouf, Síle F. Molloy et al. · Trials · 2018 · 46 citations · Full text

Severe Thrombocytopenia after Zika Virus Infection, Guadeloupe, 2016

Timothée Boyer‐Chammard, Kinda Schepers, Sébastien Breurec et al. · Emerging infectious diseases · 2016 · 40 citations · Full text

Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial

David S. Lawrence, Charles Muthoga, David B. Meya et al. · The Lancet Global Health · 2022 · 29 citations · Full text

Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease

Mark W. Tenforde, Timothée Boyer‐Chammard, Charles Muthoga et al. · Journal of Clinical Microbiology · 2020 · 17 citations · Full text

Reduction in mortality from HIV-related CNS infections in routine care in Africa (DREAMM): a before-and-after, implementation study

Sayoki Mfinanga, Cecilia Kanyama, Charles Kouanfack et al. · The Lancet HIV · 2023 · 16 citations · Full text